Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 17, 2024 | NewBiologix Abstracts Selected for Two Poster Presentations at European Society of Gene & Cell Therapy 2024 Congress | Posters feature innovative technologies that address limitations of gene therapy production LAUSANNE, SWITZERLAND, October 17, 2024 /EINPresswire.com/ -- NewBiologix SA, a technology innovation company pioneering innovative solutions to ena... |
| Sep 5, 2024 | Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule | STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announc... |
Reviews 0
FAQ about ESGCT Congress
What has the press written about ESGCT Congress?
Parsers VC has collected 3 articles mentioning ESGCT Congress, among them “NewBiologix Abstracts Selected for Two Poster Presentations at European Society of Gene & Cell Therapy 2024 Congress” (Oct 17, 2024) and “Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule” (Sep 5, 2024).
Is ESGCT Congress still active?
Yes, ESGCT Congress is active; its latest activity on Parsers VC dates from Sep 26, 2025.